Financials of Accretion Pharmaceuticals Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Accretion Pharmaceuticals Ltd

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Accretion Pharmaceuticals Ltd

Profit & Loss

Annual income statement trend

Mar 2024Mar 2025Mar 2026
Sales +13.3557.3889.63
Expenses +10.7845.4974.68
Operating Profit2.5711.8914.95
OPM %19.25%20.72%16.68%
Other Income +0.050.090.19
Interest0.401.440.85
Depreciation0.220.771.21
Profit before tax2.009.7713.08
Tax %25.00%30.40%26.15%
Net Profit +1.496.799.67
EPS in Rs3.728.318.70
Dividend Payout %0.00%0.00%0.00%

Financials of Accretion Pharmaceuticals Ltd

Balance Sheet

Capital structure and asset base

Mar 2024Mar 2025Mar 2026
Equity Capital4.008.1711.12
Reserves1.497.1243.59
Borrowings +13.4814.1012.32
Other Liabilities +8.4710.489.63
Total Liabilities27.4439.8776.66
Fixed Assets +5.256.0913.21
CWIP0.000.000.20
Investments0.000.000.00
Other Assets +22.1933.7863.25
Total Assets27.4439.8776.66

Financials of Accretion Pharmaceuticals Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-11.515.75-14.62
Cash from Investing Activity +-5.48-1.61-8.53
Cash from Financing Activity +17.08-4.1827.12
Net Cash Flow0.09-0.043.97
Free Cash Flow-16.994.14-23.15
CFO/OP-479%64%-75%

Financials of Accretion Pharmaceuticals Ltd

Ratios

Working capital efficiency and return ratios

Mar 2024Mar 2025Mar 2026
Debtor Days158.5874.1791.22
Inventory Days564.06188.49158.92
Days Payable256.3269.4132.32
Cash Conversion Cycle466.31193.25217.82
Working Capital Days189.4765.33145.63
ROCE %46.36%28.89%